Recruiting Studies

RECRUITING STUDIES

The Clinical Research Department at The Polyclinic offers patients and the public the opportunity to take part in clinical trials. For each trial, a board-certified physician and study coordinator work closely with the patient to provide a predictable and comfortable experience. Trials currently enrolling new participants are listed below.   

If you are interested in participating in an enrolling trial, please contact The Polyclinic Clinical Research Department at research@polyclinic.com or (206) 320-6692.

If you qualify for a trial and are enrolled, you will receive confidential study-related medical care and treatment at no cost. Financial compensation may also be provided. 

 

Anemia in Chronic Kidney Disease

Dr. Lisa Nakamoto is conducting a study evaluating the effectiveness and safety of an investigational drug for the treatment of anemia in chronic kidney disease patients who are not on dialysis. The study drug is administered orally.
For additional information, click here.
Principal Investigator: Lisa Nakamoto, MD
Sub-Investigator: Anne Pesenson, MD
Study Coordinator: Michelle Harder, MA-C

 

Diabetes Mellitus (Type 1)

Dr. Ken Gross is conducting a study evaluating the effectiveness and safety of an investigational drug in patients with Type 1 diabetes mellitus as adjunctive to insulin therapy. The study drug is administered orally.
For additional information, click here.
Principal Investigator: Ken Gross, MD
Sub-Investigator: Michael Williams, MD
Study Coordinator: Gary Brown, CMA

 

Multiple Sclerosis (Relapsing)

Dr. Braden Nago is conducting a study evaluating the effectiveness and safety of an investigational drug in for the treatment of relapsing multiple sclerosis (RMS). The study drug is administered orally.
For additional information, click here.
Principal Investigator: Braden Nago, MD
Sub-Investigators: Meghana Doreswamy, MD; William Johnston, MD; Sameer Khan, MD; Anthony Krajcer, MD; Benduan Yang, MD
Study Coordinator: Michelle Harder, MA-C

 

Overactive Bladder

Dr. Emily Bradley is conducting a study evaluating the effectiveness and safety of Botox in achieving 100% reduction in urinary incontinence in patients with overactive bladder not properly managed with an anticholinergic.
For additional information, click here.
Principal Investigator: Emily Bradley, MD
Sub-Investigator: Van Ginger, MD, PhD
Study Coordinator: Victoria Saetern, MA-C

 

Overactive Bladder (Observational Study)

Dr. Emily Bradley is conducting a prospective, observational study to identify factors that are associated with improved effectiveness in pharmacologic therapy of overactive bladder. The study is designed to collect data from the patient perspective, primarily measured by a questionnaire.
For additional information, click here.
Principal Investigator: Emily Bradley, MD
Study Coordinator: Michelle Lim, MA-C

 

Psoriatic Arthritis

Dr. Anthony Krajcer is conducting a study evaluating the effectiveness and safety of an investigational agent in treating psoriatic arthritis. The study drug is administered by subcutaneous injection (an injection into the fatty layer of tissue just under the skin).
For additional information, click here.
Principal Investigator: Anthony Krajcer, MD
Sub-Investigator: Elton Lee, MD
Study Coordinator: Michelle Harder, MA-C

 

Secondary Stroke Prevention

Dr. Braden Nago is conducting a study comparing the effectiveness and safety of an investigational drug vs. aspirin for the prevention of stroke recurrence in patients with embolic stroke of undetermined source. The study drug is administered orally.
For additional information, click here.
Principal Investigator: Braden Nago, MD
Sub-Investigators: Alex Cooper, MD; Meghana Doreswamy, MD; MD; Benduan Yang, MD
Study Coordinator: Michelle Harder, MA-C